Physician profile
Alan Boonin
NPI 1942237961
$1,738.14
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $715 · 2020: $288 · 2021: $352 · 2022: $104 · 2023: $138 · 2024: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $393.48 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.04 | 2019-2023 | Jardiance |
| Pfizer INC. | $238.13 | 2019-2023 | |
| Novo Nordisk INC | $211.73 | 2019-2022 | |
| Glaxosmithkline, LLC. | $170.29 | 2019-2024 | Arexvy |
| Amarin Pharma, INC. | $96.78 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $92.00 | 2019-2024 | Breztri |
| Lilly USA, LLC | $47.81 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $40.62 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $33.98 | 2019 | |
| Merck Sharp & Dohme LLC | $31.61 | 2019-2023 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.91 | 2023 | Lifevest |
| Sunovion Pharmaceuticals INC. | $21.63 | 2021 | |
| Zealand Pharma US, INC. | $18.71 | 2021 | |
| Esperion Therapeutics, INC. | $16.76 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $16.68 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $14.47 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.09 | 2021 | |
| Allergan, INC. | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Boonin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.